HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Massimo Mannelli Selected Research

Multiple Endocrine Neoplasia Type 2a (MEN 2)

5/2014Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
3/2011Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma.
2/2011Age at diagnosis of pheochromocytoma differs according to catecholamine phenotype and tumor location.
2/2011Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.
8/2009An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
11/2008Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma.
8/2005Phaeochromocytoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Massimo Mannelli Research Topics

Disease

59Neoplasms (Cancer)
10/2021 - 03/2002
29Pheochromocytoma
01/2022 - 03/2002
26Paraganglioma (Paragangliomas)
01/2022 - 08/2006
15Adrenocortical Carcinoma
10/2021 - 03/2005
12Adenoma (Adenomas)
01/2018 - 03/2004
10Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2021 - 03/2005
7Hyperaldosteronism (Conn Syndrome)
01/2018 - 08/2006
7Multiple Endocrine Neoplasia Type 2a (MEN 2)
05/2014 - 08/2005
6Hypertension (High Blood Pressure)
01/2019 - 08/2006
5Carcinoma (Carcinomatosis)
01/2021 - 03/2004
5Cushing Syndrome
04/2017 - 10/2003
5Neoplasm Metastasis (Metastasis)
10/2014 - 08/2006
4Neurofibromatosis 1 (Neurofibromatosis Type I)
02/2011 - 08/2005
3Disease Progression
01/2021 - 09/2013
3Neuroblastoma
06/2015 - 10/2013
3Graves Disease (Basedow Disease)
09/2013 - 04/2005
3von Hippel-Lindau Disease (von Hippel Lindau Disease)
08/2009 - 08/2005
2Essential Hypertension
01/2018 - 07/2008
2Adrenal Gland Neoplasms (Adrenal Cancer)
08/2016 - 03/2004
2Genetic Predisposition to Disease (Genetic Predisposition)
11/2015 - 08/2005
2Hyperplasia
10/2014 - 10/2003
2Adrenal Insufficiency (Adrenal Gland Hypofunction)
05/2014 - 01/2013
2Hyponatremia
12/2012 - 04/2007
2Adrenocortical Adenoma (Disease, Conn's)
05/2008 - 03/2004
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2007 - 04/2005
2Addison Disease (Addison's Disease)
03/2007 - 04/2005
1Dosage-sensitive sex reversal
01/2019
1Wilms Tumor (Wilm's Tumor)
01/2019
1Hypoglycemia (Reactive Hypoglycemia)
12/2018
1Insulinoma
12/2018
1Atrial Fibrillation
01/2018

Drug/Important Bio-Agent (IBA)

20Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2022 - 08/2005
16CatecholaminesIBA
01/2019 - 03/2002
12Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2005
9Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2010
8AldosteroneIBA
01/2018 - 03/2004
7Mitotane (Lysodren)FDA Link
10/2021 - 06/2007
6Pharmaceutical PreparationsIBA
02/2020 - 03/2010
6Epinephrine (Adrenaline)FDA LinkGeneric
03/2011 - 04/2005
5MicroRNAs (MicroRNA)IBA
01/2019 - 10/2013
5Adrenocorticotropic Hormone (ACTH)FDA Link
04/2017 - 03/2004
5DNA (Deoxyribonucleic Acid)IBA
01/2017 - 07/2014
5Hydrocortisone (Cortisol)FDA LinkGeneric
01/2016 - 10/2003
4Rosiglitazone (Avandia)FDA Link
10/2021 - 01/2008
4EnzymesIBA
01/2021 - 03/2007
4SteroidsIBA
01/2019 - 08/2013
4Succinic Acid (Succinate)IBA
01/2019 - 07/2014
4FumaratesIBA
01/2019 - 07/2014
4Norepinephrine (Noradrenaline)FDA LinkGeneric
07/2012 - 04/2005
4NormetanephrineIBA
07/2012 - 04/2005
4MetanephrineIBA
05/2012 - 04/2005
3Hormones (Hormone)IBA
01/2019 - 10/2003
3Myc associated factor XIBA
11/2014 - 06/2011
3Messenger RNA (mRNA)IBA
06/2013 - 03/2004
3SodiumIBA
12/2012 - 08/2007
3ReninIBA
01/2010 - 12/2006
2PPAR gammaIBA
10/2021 - 03/2005
2LigandsIBA
10/2021 - 04/2005
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
10/2020 - 10/2003
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2016 - 10/2014
2AndrogensIBA
10/2014 - 01/2013
2Vasopressins (Vasopressin)IBA
12/2012 - 10/2003
23-methoxytyramine (methoxytyramine)IBA
07/2012 - 03/2011
2Dopamine (Intropin)FDA LinkGeneric
07/2012 - 01/2012
2Glucagon (Glukagon)FDA Link
01/2010 - 11/2008
2Captopril (Capoten)FDA LinkGeneric
08/2007 - 12/2006
1Chemokine CXCL12IBA
10/2021
1Telomerase (Telomerase Reverse Transcriptase)IBA
09/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Etoposide (VP 16)FDA LinkGeneric
01/2021
1fascinIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Streptozocin (Streptozotocin)FDA Link
01/2021
1GemcitabineFDA Link
01/2021
1Capecitabine (Xeloda)FDA Link
01/2021
1cyclohexane- 1,2,4- tris(methylenesulfonate) (CTMS)IBA
10/2020
1Testosterone (Sustanon)FDA Link
10/2020
1GonadotropinsIBA
10/2020
1Cytochrome P-450 CYP2B6 (CYP2B6)IBA
02/2020
1LeptinIBA
12/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2019
1alpha-hydroxyglutarateIBA
01/2019
1Connective Tissue Growth FactorIBA
01/2019
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
01/2019
1NestinIBA
01/2019
1STA 9090IBA
01/2019
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
01/2019
1Chromogranin AIBA
01/2019
1Fumarate Hydratase (Fumarase)IBA
01/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2019
1Tumor Biomarkers (Tumor Markers)IBA
01/2019
1Cysteine-Rich Protein 61IBA
01/2019
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
12/2018
1Octreotide (Sandostatin)FDA LinkGeneric
12/2018
1Malate Dehydrogenase (Dehydrogenase, Malate)IBA
12/2018

Therapy/Procedure

10Therapeutics
10/2020 - 03/2010
4Adrenalectomy
01/2018 - 12/2006
2Drug Therapy (Chemotherapy)
01/2021 - 09/2017
2Subcutaneous Injections
08/2016 - 01/2010